Voltage-gated calcium channel-associated Lambert-Eaton myasthenic syndrome (Q96654): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed label, description and/or aliases in pt-br, en |
Changed an Item |
||
| Property / Canonical URI | |||
| Property / Canonical URI: https://id.who.int/icd/entity/97949388 / rank | |||
Normal rank | |||
Revision as of 12:41, 16 August 2026
Lambert-Eaton myasthenic syndrome is a rare human autoimmune disorder of the neuromuscular junction caused by the presence of antibodies directed against voltage-gated calcium channels localised in the presynaptic membrane of their motor nerve terminals, thus leading to reduced neuromuscular transmission. In approximately 50% of the patients, Lambert-Eaton myasthenic syndrome is reflected by a paraneoplastic manifestation and most commonly associated with a small cell lung carcinoma whose cells also express voltage-gated calcium channels in their plasma membrane.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_97949388 |
||
| English | Voltage-gated calcium channel-associated Lambert-Eaton myasthenic syndrome |
Lambert-Eaton myasthenic syndrome is a rare human autoimmune disorder of the neuromuscular junction caused by the presence of antibodies directed against voltage-gated calcium channels localised in the presynaptic membrane of their motor nerve terminals, thus leading to reduced neuromuscular transmission. In approximately 50% of the patients, Lambert-Eaton myasthenic syndrome is reflected by a paraneoplastic manifestation and most commonly associated with a small cell lung carcinoma whose cells also express voltage-gated calcium channels in their plasma membrane. |
